642 related articles for article (PubMed ID: 2580891)
1. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
Aberer W; Kruisbeek AM; Shimada S; Katz SI
J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
[TBL] [Abstract][Full Text] [Related]
3. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
6. In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.
Kruisbeek AM; Bridges S; Carmen J; Longo DL; Mond JJ
J Immunol; 1985 Jun; 134(6):3597-604. PubMed ID: 3157745
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
Ono S; Takahama Y; Hamaoka T
J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
[TBL] [Abstract][Full Text] [Related]
8. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
9. Ek beta mutant antigen-presenting cell lines expressing altered Ak alpha molecules.
Quill H; Schwartz RH; Glimcher LH
J Immunol; 1986 May; 136(9):3351-9. PubMed ID: 3082986
[TBL] [Abstract][Full Text] [Related]
10. Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes.
Scalzo AA; Anders EM
J Immunol; 1985 Nov; 135(5):3524-9. PubMed ID: 3876388
[TBL] [Abstract][Full Text] [Related]
11. Two roles for Ia in antigen-specific T lymphocyte activation.
Kim KH; Shivdasani RA; Thomas DW
J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
[TBL] [Abstract][Full Text] [Related]
12. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
13. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.
Germain RN; Bhattacharya A; Dorf ME; Springer TA
J Immunol; 1982 Mar; 128(3):1409-13. PubMed ID: 6173436
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
[TBL] [Abstract][Full Text] [Related]
15. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome.
Schurmans S; Heusser CH; Qin HY; Merino J; Brighouse G; Lambert PH
J Immunol; 1990 Oct; 145(8):2465-73. PubMed ID: 2212649
[TBL] [Abstract][Full Text] [Related]
17. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
Perry LL; Williams IR
J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.
Abe R; Hodes RJ
J Immunol; 1988 Jun; 140(12):4132-8. PubMed ID: 2453568
[TBL] [Abstract][Full Text] [Related]
19. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
20. The T cell response to allelic determinants on Igh-1-encoded IgG2a antibodies: dual recognition examined by using antigenic antibodies with binding affinity for Ia molecules.
Hedrick SM; Schwartz RH
J Immunol; 1983 Apr; 130(4):1958-66. PubMed ID: 6187829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
